These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 29428667)
21. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice. Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154 [TBL] [Abstract][Full Text] [Related]
22. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529 [TBL] [Abstract][Full Text] [Related]
23. Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation. Sena CM; Cipriano MA; Botelho MF; Seiça RM Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208622 [TBL] [Abstract][Full Text] [Related]
24. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice. Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662 [TBL] [Abstract][Full Text] [Related]
25. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944 [TBL] [Abstract][Full Text] [Related]
26. Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. Valenzuela R; Espinosa A; Llanos P; Hernandez-Rodas MC; Barrera C; Vergara D; Romero N; Pérez F; Ruz M; Videla LA Food Funct; 2016 Jan; 7(1):140-50. PubMed ID: 26471014 [TBL] [Abstract][Full Text] [Related]
27. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819 [TBL] [Abstract][Full Text] [Related]
28. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220 [TBL] [Abstract][Full Text] [Related]
29. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease. Lai YS; Lee WC; Lin YE; Ho CT; Lu KH; Lin SH; Panyod S; Chu YL; Sheen LY J Agric Food Chem; 2016 Mar; 64(10):2062-71. PubMed ID: 26900108 [TBL] [Abstract][Full Text] [Related]
30. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet. Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423 [TBL] [Abstract][Full Text] [Related]
31. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Ji Y; Gao Y; Chen H; Yin Y; Zhang W Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484323 [TBL] [Abstract][Full Text] [Related]
32. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation. Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380 [TBL] [Abstract][Full Text] [Related]
33. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression. Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851 [TBL] [Abstract][Full Text] [Related]
34. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid. Wang J; Jiang W Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851 [TBL] [Abstract][Full Text] [Related]
35. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice. Lin CH; Kuo YH; Shih CC Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085 [TBL] [Abstract][Full Text] [Related]
36. The PKA-SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet-Induced Fatty Liver in Mice. Hong E; Kang H; Yang G; Oh S; Kim E Mol Nutr Food Res; 2023 Oct; 67(20):e2200496. PubMed ID: 37650271 [TBL] [Abstract][Full Text] [Related]